Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery

Review

Published on 26 Mar 2025

Comprehensive mini-review: therapeutic potential of cannabigerol – focus on the cardiovascular system

in Experimental Pharmacology and Drug Discovery

Anna Krzyżewska
Monika Kloza
Hanna Kozłowska

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561385

547 views

Original Research

Published on 26 Mar 2025

Rhodiola crenulata polysaccharide alleviates dextran sulfate sodium-induced ulcerative colitis in mice by repairing the intestinal barrier and regulating the intestinal microecology

in Experimental Pharmacology and Drug Discovery

Jia Lv
Xinyu Kong
Wenjun Liu
Zhenzhen Su
Fengshou Luo
Fengtai Suo
Zhenzhong Wang
Liang Cao
Zhongqiu Liu
Mengxuan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519038

630 views

Review

Published on 25 Mar 2025

Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models

in Experimental Pharmacology and Drug Discovery

Kai Zhang
Rui Ran
Cheng-Jun Zhang
Linna Wang
Hai-Hong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555732

763 views

Editorial

Published on 25 Mar 2025

Editorial: Debates in experimental pharmacology and drug discovery 2023: innovative approaches to chronic kidney disease drug discovery, identification of targets and safety assessment

in Experimental Pharmacology and Drug Discovery

Md Abdul Hye Khan
Omar Z. Ameer
Samaneh Goorani
Ibrahim M. Salman

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588367

443 views

Review

Published on 25 Mar 2025

Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine

in Experimental Pharmacology and Drug Discovery

Ziyi Zhu
Jiayang Shen
Paul Chi-Lui Ho
Ya Hu
Zhaowu Ma
Lingzhi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563198

840 views

Original Research

Published on 25 Mar 2025

The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis

in Experimental Pharmacology and Drug Discovery

Bashaier Al-Zaid
Suleiman Al-Sabah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528295

792 views

Review

Published on 24 Mar 2025

Solanesol: a promising natural product

in Experimental Pharmacology and Drug Discovery

Yinchao Ma
Ge Wei
Zhichen Dong
Ziyuan Wang
Xinlong Zhai
Yuan Liu
Huan Chen
Yaning Fu
Hongwei Hou
Qingyuan Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1504245

750 views

Original Research

Published on 24 Mar 2025

New use of an old drug: mechanism of oseltamivir phosphate inhibiting liver cancer through regulation of lipophagy via NEU1

in Experimental Pharmacology and Drug Discovery

Yuyu Chen
Peiyu Han
Haixia Zhu
Wenchao Zhang
Xiaoyu Ma
Yiting He
Hetian Chen
Weiwei He
Yu Wu
Yuqiu Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556661

668 views

Review

Published on 21 Mar 2025

Application of high-dose tranexamic acid in the perioperative period: a narrative review

in Experimental Pharmacology and Drug Discovery

Yushan Duan
Xiaohong Wan
Yiming Ma
Weihua Zhu
Yue Yin
Qingqing Huang
Yuan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552511

1,163 views

Editorial

Published on 21 Mar 2025

The Necessity for Polypharmacological Research – An Editorial on ‘Network Polypharmacology of ATP-binding Cassette (ABC) and Solute Carrier (SLC) Transporters’

in Experimental Pharmacology and Drug Discovery

Muhammad Rafehi
Kapil Juvale
Lukasz Pulaski
Sven Marcel Stefan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561247

445 views

Editorial

Published on 21 Mar 2025

Editorial: Targeting mitochondria in aging and disease

in Experimental Pharmacology and Drug Discovery

Cara B. Gonzales
John M. Seubert
Antonio Marcus Paes

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1589728

689 views

Original Research

Published on 20 Mar 2025

The role of atropine in myopia control: insights into choroidal and scleral mechanisms

in Experimental Pharmacology and Drug Discovery

Longxiang Huang
Jingjin Zhang
Youfang Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1509196

893 views

Review

Published on 20 Mar 2025

MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck

in Experimental Pharmacology and Drug Discovery

Dennis Christoph Harrer
Florian Lüke
Tobias Pukrop
Lina Ghibelli
Albrecht Reichle
Daniel Heudobler

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1553331

610 views

Original Research

Published on 20 Mar 2025

Ultrasound-assisted H2O2 degradation enhances the bioactivity of Schizophyllan for wound healing and tissue regeneration

in Experimental Pharmacology and Drug Discovery

Hui He
Yu Liu
Qingpeng Li
Fenrou Chen
Lin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562839

501 views

Original Research

Published on 19 Mar 2025

Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota

in Experimental Pharmacology and Drug Discovery

Zu-Wen Ye
Qi-Yue Yang
Dong-Hua Yang
Qiao-Hong Lin
Xiao-Xia Liu
Feng-Qin Li
Fang-Fang Yan
Ping Luo
Si Qin
Fang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565030

632 views

Review

Published on 19 Mar 2025

The potential of ARL4C and its-mediated genes in atherosclerosis and agent development

in Experimental Pharmacology and Drug Discovery

Dan Liu
Jie Wang
Shuangshuang Zhang
Hongfei Jiang
Yudong Wu
Chao Wang
Wujun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1513340

712 views